Biostem Technologies

Biostem Technologies Enterprise Value

The Enterprise Value (EV) of Biostem Technologies (BSEM) as of Oct 8, 2026 is 94.91 M USD. In the previous year, Enterprise Value (EV) was 95.03 M USD — a change of -0.12% (lower).

Enterprise Value

94.91 MUSD

YoY

-0.12%

Last updated:

Enterprise Value (EV) of Biostem Technologies is 2024 94.91 M USD. Enterprise Value (EV) of Biostem Technologies was 2023 95.03 M USD. It decreases by -0.12% lower compared to the previous year.

The Biostem Technologies Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2017
94.76 M USD
Jan 1, 2018
95.23 M USD
Jan 1, 2019
95.68 M USD
Jan 1, 2020
96.08 M USD
Jan 1, 2021
96.56 M USD
Jan 1, 2022
95.79 M USD
Jan 1, 2023
95.03 M USD
Jan 1, 2024
94.91 M USD
The Biostem Technologies Enterprise Value history
YEAREnterprise ValueYoY
94.91 MUSD-0.12%
95.03 MUSD-0.79%
95.79 MUSD-0.80%
96.56 MUSD+0.50%
96.08 MUSD+0.42%
95.68 MUSD+0.47%
95.23 MUSD+0.49%
94.76 MUSD0.00%
94.76 MUSD0.00%
94.76 MUSD0.00%
94.76 MUSD—
Access this data via the Eulerpool API

Biostem Technologies Stock analysis

What does Biostem Technologies do? Biostem Technologies Inc is a US company specializing in regenerative medicine. It was founded in 2007 and is based in Clearwater, Florida. Biostem Technologies is listed on the OTCQB Stock Exchange and offers a wide range of products in the field of regenerative medicine. The company's business model primarily involves advancing growth in the field of regenerative medicine through the development and marketing of new products and technologies. They focus on the production of stem cells that can be used in the regeneration of damaged tissues and organs. They also offer research and development of stem cell therapies, manufacturing of stem cell products, and related services. Biostem Technologies places emphasis on processing umbilical cord blood stem cells, collaborating with medical facilities to collect and isolate these cells for preservation. The company has also developed products such as BioStem Serum and BioStem Gel, made from stem cells and used in regeneration and wound healing. They have developed technologies for regenerating damaged tissues and organs, including a technology for regenerating muscle and adipose tissue through stem cell injection. Clinical studies have shown promising results with this technology. Biostem Technologies has partnerships with other companies and institutes in the field of regenerative medicine, including working with the National Institute of Neurological Disorders and Stroke to develop a new therapy for multiple sclerosis. They also provide consulting services to assist other companies in developing regenerative products and services. In conclusion, Biostem Technologies is a leading company in the field of regenerative medicine and stem cell therapies, offering a range of products and services. They also provide important technologies for tissue regeneration, positioning them as a key player in the field of regenerative medicine. Biostem Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biostem Technologies stock

Enterprise Value (EV) of Biostem Technologies is 94.91 M USD in 2024.

Enterprise Value (EV) of Biostem Technologies changed from 95.03 M USD to 94.91 M USD, representing a -0.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Biostem Technologies since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Biostem Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Biostem Technologies

All Key Metrics — Biostem Technologies